Related Experiment Videos
[Severe hepatitis attributed to paroxetine (Seroxat)]
1Academisch Ziekenhuis Rotterdam-Dijkzigt, afd. Maag-, Darm- en Leverzieklen.
Nederlands Tijdschrift Voor Geneeskunde
|March 15, 1997
Summary
Long-term paroxetine treatment for depression can cause severe liver issues in patients with chronic hepatitis B related liver cirrhosis. Discontinue paroxetine if liver function declines in these patients.
Area of Science:
- Hepatology
- Pharmacology
- Clinical Medicine
Background:
- Chronic hepatitis B infection can lead to liver cirrhosis, a condition affecting liver function.
- Depression is a common comorbidity, often treated with selective serotonin reuptake inhibitors like paroxetine.
Observation:
- A 52-year-old male patient with liver cirrhosis due to hepatitis B developed severe hepatitis and liver failure after initiating paroxetine (Serotax) for depression.
- Symptoms included jaundice, hypoalbuminemia, edema, and ascites, which resolved upon drug discontinuation.
Findings:
- The adverse reaction suggests altered paroxetine pharmacokinetics in patients with liver cirrhosis.
- This case highlights a potential drug-induced liver injury exacerbated by pre-existing liver disease.
Implications:
- Caution is advised when prescribing long-term paroxetine to patients with liver cirrhosis.
- Regular liver function monitoring and prompt drug withdrawal are crucial for managing potential adverse effects.